GMI

The CB2 cannabinoid agonist AM-1241 prolongs survival (56%) in a transgenic mouse model of amyotrophic lateral sclerosis when initiated at symptom onset.


Comments

Leave a Reply

Your email address will not be published. Required fields are marked *